Kande Amarasinghe

Title: Kande Amarasinghe: Innovator in Protein Tyrosine Phosphatase Inhibitors

Introduction

Kande Amarasinghe is an inventor based in the United States. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that act as human protein tyrosine phosphatase beta (HPTP-β) inhibitors. Although he currently holds 0 patents, his work has the potential to impact the regulation of angiogenesis.

Latest Patents

Amarasinghe's latest patents focus on human protein tyrosine phosphatase inhibitors and their methods of use. The present disclosure relates to compounds effective as HPTP-β inhibitors, which play a crucial role in regulating angiogenesis. These compounds are accompanied by compositions that include the HPTP-β inhibitors, as well as methods for their application in regulating angiogenesis.

Career Highlights

Throughout his career, Kande Amarasinghe has worked with notable companies such as Aerpio Therapeutics, Inc. and Warner Chilcott Company, LLC. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to innovative research.

Collaborations

Some of Kande Amarasinghe's coworkers include Jeffrey Lyle Gray and Cynthia Monesa Clark. Their collaborative efforts have likely enhanced the research and development of the compounds he has worked on.

Conclusion

Kande Amarasinghe is a dedicated inventor whose work in protein tyrosine phosphatase inhibitors holds promise for future advancements in the regulation of angiogenesis. His contributions to the field, along with his collaborations, highlight the importance of innovation in biochemistry.